Arcus Biosciences, Inc. (RCUS) Total Assets by Year
Arcus Biosciences, Inc. closed fiscal year 2025 with $1.1B in total assets, $508.0M in total liabilities and $631.0M in shareholder equity. This represents a decrease of 1.0% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Arcus Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RCUS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B-1.0% | $1.1B+5.0% | $1.1B-18.6% | $1.3B-15.5% | $1.6B+106.1% | $772.3M+280.2% | $203.1M-26.1% | $274.9M+44.3% | $190.5M | N/A |
| Total Liabilities | $508.0M-23.6% | $665.0M+5.1% | $633.0M-8.0% | $688.0M-8.3% | $750.4M+178.0% | $270.0M+587.6% | $39.3M-1.8% | $40.0M-84.8% | $262.8M | N/A |
| Total Equity | $631.0M+30.1% | $485.0M+5.0% | $462.0M-29.7% | $657.0M-22.0% | $842.0M+67.7% | $502.0M+206.1% | $164.0M-30.2% | $234.9M+424.8% | -$72.3M-261.7% | -$20.0M |
RCUS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $924.0M-14.0% | $997.0M-13.8% | $1.1B-1.0% | $974.0M-22.2% | $1.1B-9.4% | $1.2B-10.6% | $1.1B+5.0% | $1.3B+5.1% | $1.2B-2.8% | $1.3B+3.1% | $1.1B-18.6% | $1.2B-14.6% |
| Total Liabilities | $460.0M-12.5% | $473.0M-24.3% | $508.0M-23.6% | $538.0M-21.7% | $526.0M-4.5% | $625.0M+6.7% | $665.0M+5.1% | $687.0M+2.4% | $551.0M-15.7% | $586.0M-10.4% | $633.0M-8.0% | $671.0M-3.5% |
| Total Equity | $464.0M-15.5% | $524.0M-1.3% | $631.0M+30.1% | $436.0M-22.8% | $549.0M-13.5% | $531.0M-24.9% | $485.0M+5.0% | $565.0M+8.7% | $635.0M+12.2% | $707.0M+17.8% | $462.0M-29.7% | $520.0M-25.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Arcus Biosciences, Inc. financials
Frequently Asked Questions
What was Arcus Biosciences, Inc.'s total assets in fiscal year 2025?
Arcus Biosciences, Inc. closed fiscal year 2025 with $1.1B in total assets, $508.0M in total liabilities and $631.0M in shareholder equity.
How fast is Arcus Biosciences, Inc.'s total assets growing?
Arcus Biosciences, Inc. (RCUS) total assets fell by 1.0% year over year, from $1.1B to $1.1B in fiscal year 2025.
What was Arcus Biosciences, Inc.'s total assets in the most recent quarter?
Arcus Biosciences, Inc. (RCUS) reported $924.0M in total assets in Q2 2026. This represents a decrease of 14.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Arcus Biosciences, Inc. (RCUS) reported on that line in every period on record.